Hecht, Markus http://orcid.org/0000-0003-2082-216X
Hahn, Dennis
Wolber, Philipp
Hautmann, Matthias G.
Reichert, Dietmar
Weniger, Steffi
Belka, Claus
Bergmann, Tobias
Göhler, Thomas
Welslau, Manfred
Große-Thie, Christina
Guntinas-Lichius, Orlando
von der Grün, Jens
Balermpas, Panagiotis
Orlowski, Katrin
Messinger, Diethelm
Stenzel, Karsten G.
Fietkau, Rainer
Funding for this research was provided by:
Merck KGaA
Article History
Received: 30 May 2020
Accepted: 21 September 2020
First Online: 29 September 2020
Ethics approval and consent to participate
: The institutional review board at the Friedrich-Alexander-Universität Erlangen-Nürnberg (number: 84_12 B) approved the non-interventional trial. All patients gave written informed consent before enrollment.
: The manuscript does not contain any individual person’s data.
: M.H. conflict of interest with Merck Serono (advisory boards, honoraria for lectures, travel grants, research funding); MSD (advisory boards, travel grants, research funding); AstraZeneca (research funding); Novartis (research funding); BMS (advisory boards, honoraria for lectures); Teva (travel grants). M.G.H. conflict of interest with MerckSerono (honoraria as speaker and author) as well as honoraria, travel grant from AstraZeneca, MSD, BMS, Celgene. M.W. no conflict of interest with Merck Serono; conflict of interest with other companies (AMGEN, Astellas, AstraZeneca, Celgene, Gilead, Hexal, Janssen, Lilly, Novartis, Roche, SANOFI). C.G.T. conflict of interest with Merck Serono (speaker fee); conflict of interest with other companies (speaker fee: Amgen, Celgene, Novartis, BMS; travel grants: Daiichi Sankyo, Alexion, BMS, Novartis). O.G.L received lecture fees and travel grants from Merck Serono. K.O. employee of Merck Serono. D.M. employee of Prometris GmbH which provides statistical services for Merck Serono. K.G.S. employee of Merck Serono. R.F. conflict of interest with Merck Serono (AdBoard, Honoraria, Research funding); AstraZeneca (AdBoard, Honoraria, Research funding); MSD (AdBoard, Honoraria, Research funding); Novocure (AdBoard, Honoraria, Research funding); Brainlab (AdBoard, Honoraria, Research funding); Fresenius Kabi (AdBoard, Honoraria, Research funding); BMS (AdBoard, Honoraria, Research funding); Sennewald (Honoraria). The other authors declare no conflict of interest.